These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses. Manallack DT; Wong MG; Costa M; Andrews PR; Beart PM Mol Pharmacol; 1988 Dec; 34(6):863-79. PubMed ID: 2849051 [TBL] [Abstract][Full Text] [Related]
46. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays. Contreras PC; Quirion R; O'Donohue TL NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347 [No Abstract] [Full Text] [Related]
47. Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites. Roman FJ; Pascaud X; Duffy O; Vauche D; Martin B; Junien JL Eur J Pharmacol; 1989 Dec; 174(2-3):301-2. PubMed ID: 2560982 [No Abstract] [Full Text] [Related]
48. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20. Kushner L; Zukin SR; Zukin RS Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188 [TBL] [Abstract][Full Text] [Related]
49. Isolation and identification of an endogenous ligand for the phencyclidine receptor. DiMaggio DA; Contreras PC; Quirion R; O'Donohue TL NIDA Res Monogr; 1986; 64():24-36. PubMed ID: 3012346 [No Abstract] [Full Text] [Related]
50. Dextromethorphan binding sites in the guinea pig brain. Musacchio JM; Klein M Cell Mol Neurobiol; 1988 Jun; 8(2):149-56. PubMed ID: 3044591 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands. Costantino L; Gandolfi F; Sorbi C; Franchini S; Prezzavento O; Vittorio F; Ronsisvalle G; Leonardi A; Poggesi E; Brasili L J Med Chem; 2005 Jan; 48(1):266-73. PubMed ID: 15634021 [TBL] [Abstract][Full Text] [Related]
52. Characterization of (+)-[3H]3-PPP and [3H]TCP binding sites in membrane preparations of bovine adrenal medulla. Rogers CA; Lemaire S Prog Clin Biol Res; 1990; 328():133-6. PubMed ID: 2154767 [No Abstract] [Full Text] [Related]
54. Down-regulation of sigma receptors by chronic haloperidol. Matsumoto RR; Bowen WD; Walker JM Prog Clin Biol Res; 1990; 328():125-8. PubMed ID: 2154764 [No Abstract] [Full Text] [Related]
55. Allosteric modulation of dextromethorphan binding sites. Musacchio JM; Klein M; Santiago LJ Neuropharmacology; 1987 Jul; 26(7B):997-1001. PubMed ID: 2821439 [TBL] [Abstract][Full Text] [Related]
56. Effects of haloperidol and reduced haloperidol on binding to sigma sites. Klein M; Cooper TB; Musacchio JM Eur J Pharmacol; 1994 Mar; 254(3):239-48. PubMed ID: 8013558 [TBL] [Abstract][Full Text] [Related]
57. Some aspects of opiate receptors. Herz A; Schulz R; Wüster M Adv Biochem Psychopharmacol; 1980; 21():329-37. PubMed ID: 6246748 [TBL] [Abstract][Full Text] [Related]
58. Psychotomimetic effects and sigma ligands. Connick J; Fox P; Nicholson D Trends Pharmacol Sci; 1990 Jul; 11(7):274-5. PubMed ID: 2167543 [No Abstract] [Full Text] [Related]
59. Selectivity of some "specific" opioid ligands? Fiorica-Howells E; Spector S Prog Clin Biol Res; 1990; 328():85-8. PubMed ID: 1968274 [No Abstract] [Full Text] [Related]
60. Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig. Roman F; Pascaud X; Chomette G; Bueno L; Junien JL Gastroenterology; 1989 Jul; 97(1):76-82. PubMed ID: 2542120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]